Molecular epidemiology of Haemophilus ducreyi infections. 1981

H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes

Haemophilus ducreyi was isolated with an enriched chocolate agar containing vancomycin from seven patients with clinical evidence of chancroid. Four cases were imported from outside the United States; the other three cases were acquired in the United States from one of the imported cases. All strains of H. ducreyi contained ampicillin-resistance plasmids with molecular weights of 7.3, 5.7, or 3.6 megadaltons. Plasmid molecular weights were identical for isolates from the epidemiologically linked cases and differed according to the geographic origins of the strains. Findings of this study confirm that H. ducreyi is sexually transmitted and suggest that clinical chancroid develops frequently after acquisition of H. ducreyi.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002602 Chancroid Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.
D005260 Female Females
D006191 Haemophilus ducreyi A species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID. Bacillus ulceris cancrosi,Coccobacillus ducreyi,Hemophilus ducreyi
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
January 2016, Emerging infectious diseases,
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
June 1982, Antimicrobial agents and chemotherapy,
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
December 1982, The Journal of hygiene,
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
January 1992, Sexually transmitted diseases,
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
August 1985, Antimicrobial agents and chemotherapy,
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
December 1983, Lancet (London, England),
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
January 1993, International journal of STD & AIDS,
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
May 1985, Infection control : IC,
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
October 1989, Archives of dermatology,
H H Handsfield, and P A Totten, and C L Fennel, and S Falkow, and K K Holmes
October 1983, Lancet (London, England),
Copied contents to your clipboard!